ELDN

Eledon Pharmaceuticals Appoints Eliezer Katz As Chief Medical Officer

(RTTNews) - Eledon Pharmaceuticals, Inc. (ELDN) announced on Monday that it has appointed Eliezer Katz as chief medical officer.

Katz is a transplant surgeon and was the chief medical officer of eGenesis. Prior to eGenesis he has held many senior roles in companies like Viela Bio, Horizon Therapeutics MedImmune Inc. and many more.

On Thursday, Eledon shares closed at $1.3, down 2.25% on Nasdaq.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.